首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >The effect of depressive symptoms on survival in peritoneal dialysis patients.
【24h】

The effect of depressive symptoms on survival in peritoneal dialysis patients.

机译:抑郁症状对腹膜透析患者生存的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: There is little information on the relationship between depressive symptoms and survival in peritoneal dialysis (PD) patients. We examined whether a single measurement of depressive symptoms using a simple self-administered tool predicts survival. DESIGN: Screening test of depressive symptoms as a predictor of outcome. SETTING: Three dialysis centers in Southwestern Pennsylvania. PARTICIPANTS: 66 adult PD subjects were screened in 1997-1998 for depression using the Zung scale. MAIN OUTCOME MEASURES: Baseline data collection included assessments of comorbidity, residual renal function, total Kt/V, nPNA, previous renal transplant, and serum albumin. Outcomes were collected prospectively after completion of the depression survey to 12/01. Cox regression analysis of patient survival was performed using all cofactors with p < 0.05 on univariate analysis. RESULTS: One third of patients had depressive symptoms. Compared to nondepressed patients, depressive symptom patients were older (62.5 vs 52.5 years, p = 0.012), had borderline lower serum albumin levels (3.47 vs 3.70 g/dL, p = 0.058), and were more disabled (Karnofsky score 70 vs 90, p< 0.001), but had similar Kt/V, residual renal function, and previous time on PD at the point of the testing. Using multivariate analysis and controlling for comorbidity (using a measurement that includes diabetes mellitus and age) and serum albumin, the survival of patients with depressive symptoms was significantly reduced compared to nondepressed patients. CONCLUSION: A single measurement of depressive symptoms using a simple self-administered test was an independent predictor of death in a cohort of PD patients, which extends observations in hemodialysis patients. Screening for depressive symptoms should be routine for dialysis patients, and those depressed should have thorough assessment and treatment. Whether treating depression will have an impact on survival is unclear and needs to be studied.
机译:目的:关于腹膜透析(PD)患者抑郁症状与生存率之间关系的信息很少。我们检查了使用简单的自我管理工具对抑郁症状的单一测量是否可以预测生存。设计:筛查抑郁症状作为预后的指标。地点:宾夕法尼亚州西南部的三个透析中心。参加者:1997-1998年使用Zung量表筛选了66名成年PD受试者。主要观察指标:基线数据收集包括合并症,残余肾功能,总Kt / V,nPNA,先前的肾移植和血清白蛋白的评估。抑郁调查完成后至12/01,前瞻性收集结果。使用所有辅助因子进行患者生存率的Cox回归分析,单因素分析的p <0.05。结果:三分之一的患者有抑郁症状。与非抑郁症患者相比,抑郁症症状患者年龄较大(62.5 vs 52.5岁,p = 0.012),血清白蛋白水平较低(3.47 vs 3.70 g / dL,p = 0.058),并且残疾程度更高(Karnofsky评分70 vs 90) ,p <0.001),但在测试时具有相似的Kt / V,残余肾功能和之前的PD时间。使用多变量分析并控制合并症(使用包括糖尿病和年龄的测量方法)和血清白蛋白,与未抑郁的患者相比,患有抑郁症状的患者的存活率显着降低。结论:使用简单的自我管理的测试对抑郁症状的单项测量是PD患者队列中死亡的独立预测因素,这扩大了血液透析患者的观察范围。透析患者应常规筛查抑郁症状,抑郁者应进行全面评估和治疗。治疗抑郁症是否会影响生存尚不清楚,需要研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号